Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-26T03:14:23.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding the details of a clinical study on ligelizumab for chronic spontaneous urticaria, including its purpose, methodology, and key inclusion/exclusion criteria. Additionally, there are updates to the revision number and masking description.
    Difference
    14%
    Check dated 2025-04-18T22:15:18.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-04T15:54:12.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-03-28T05:09:50.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-03-06T14:29:17.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, which are currently experiencing heavy traffic that may impact performance and availability.
    Difference
    0.6%
    Check dated 2025-02-12T08:38:29.000Z thumbnail image

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.